MAGED2 RNA expression was positively correlated with EPI resistance in breast cancer cell lines, although this correlation did not reach statistical significance (Fig. 1 K).
← all excerpts
Targeting the MAGED2-TRIM28-FLNC axis overcomes chemoresistance in TNBC via EMT suppression.
1
—
—